Search
for
Sort by
Research 511–540 of 863
- Bloch-Sulzberger Syndrome: A Rare X-Linked Dominant Genetic Disorder in a Newborn
- SULFUR TREATMENT FOR SCABIOSIS IN LOCAL PUPPY
- Severe cutaneous adverse reactions to drugs
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Psoriasis of the Scalp
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- The Chicken Frizzle Feather Is Due to an α-Keratin (KRT75) Mutation That Causes a Defective Rachis
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Tinea Capitis: An Overview with Emphasis on Management
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Revisiting dandruff
- Toxic Epidermal Necrolysis
- Interventions for nail psoriasis
- DRUG‐ASSOCIATED ALOPECIA
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Adverse Reactions to Oral Retinoids An Update
- Type 1 interferon signature in the scalp lesions of alopecia areata
- Oral Retinoids in Dermatology
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Autoimmunity and autoimmune co-morbidities in psoriasis
- TOXIC EPIDERMAL NECROLYSIS
- Hormonal treatment of acne vulgaris: an update
- Telogen Effluvium due to Recombinant Interferon α-2b
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Adverse Cutaneous Reactions to Antidepressants
- Side effects of common acne treatments
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Pemphigus and associated comorbidities: a cross-sectional study